Pelargonium graveolens essential oil as a pulpotomy agent for primary teeth
Official title: Clinical and Radiographic Evaluation of Pelargonium Graveolens Essential Oil as a Pulpotomy Agent in Primary Teeth
Run by Tanta University · NCT07386925 · Data updated 2026-11-12
This study tests whether rose geranium oil can be used as a pulpotomy medicament in kids’ primary molars to preserve tooth function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 7 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 2 sites (Tanta, Cairo Governorate and 1 other locations) |
| Status | Recruiting |
| Started | February 5, 2026 |
| Main results expected | October 2026 |
| Study ends | November 2026 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT07386925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children with restorable primary molars affected by reversible pulpitis or requiring pulpotomy due to deep caries.
✕Probably not a fit
Patients with irreversible pulpitis, non-restorable teeth, or signs of periapical pathology may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial evaluates the use of Pelargonium graveolens essential oil as an alternative pulpotomy medicament in restorable primary molars with reversible pulpitis. It focuses on safety and performance compared with standard expectations for maintaining tooth vitality and structure. The approach leverages the oil’s antimicrobial and biocompatible properties, aiming to reduce inflammation and promote favorable healing. Participants are children requiring pulpotomy in primary molars, with careful screening for radiographic and clinical criteria. The investigation adheres to clinical research standards and prioritizes patient safety and ethical considerations.
Why it matters
Potential benefit: If successful, children may benefit from a more biocompatible pulpotomy agent that preserves tooth integrity and function.
How similar studies have gone: Other studies in dental materials show promise for plant-derived agents, but this specific use as a pulpotomy medicament is relatively novel with limited clinical data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Restorable primary molars with deep carious lesions. * Absence of gingival swelling or sinus tract. * Absence of spontaneous pain * Absence of pain on percussion. * Absence of discontinuity of lamina dura * Absence of internal root resorption. * Absence of external root resorption. * Absence of inter-radicular or periapical bone destruction (radiolucency). Exclusion Criteria: * presence of spontaneous pain * presence of gingival swelling or sinus tract * presence of internal or external root resorption * pain on percussion.
Where it's running
-
faculty of dentistry, Tanta university
Tanta, Cairo Governorate, Egypt Recruiting -
faculty of dentistry, Tanta university
Tanta, Egypt Not yet recruiting
Study contacts
- Principal investigator: shimaa Hadwa — shimaa.hadwa@dent.tanta.edu.eg
- Study coordinator: shaimaa eldesouky, assistant professor
- Email: shaimaaeldesouky@dent.tanta.edu.eg
- Phone: +201008994242
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparison of two ways to numb a child's jaw during a root canal in the back teeth
This study tests whether digital anesthesia works as well as the traditional nerve block for numbing kids' lower back teeth during emergency root canals.
-
Pomegranate Peel Extract for Primary Molars Pulpotomy
This study tests whether pomegranate peel extract can be used to treat exposed pulp in primary molars in children, compared with the standard MTA treatment.
-
Impact of Symptoms and Lesion Depth on Partial Carious Tissue Removal
This study is trying to see how symptoms and the depth of tooth decay affect the success of removing part of the decayed tissue in adult teeth.
-
Direct pulp capping for deep and extremely deep caries in mature molars with reversible pulpitis
This study tests whether direct pulp capping works similarly for deep versus extremely deep caries in adult, mature mandibular molars with reversible pulpitis.
-
Direct pulp capping in lower molars with side (proximal) versus top (occlusal) cavities: does the cavity location matter?
This research will test whether direct pulp capping works as well for lower molars with side (proximal) cavities as for those with top (occlusal) cavities in people aged 15–40 who have reversible pulpitis.
-
Using pulpal blood biomarkers to predict success of vital pulp therapy in symptomatic teeth
This trial will test whether measuring metabolic biomarkers in pulpal blood at the time of carious pulp exposure can help predict 12-month success of vital pulp treatment in people aged 16–50 with symptomatic deep caries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.